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Background: Community health service center (CHSC) in China is always regarded as a good facility of primary
care, which plays an important role in chronic non-communicable disease management. This study aimed to
investigate the blood pressure (BP) control rate in a real life CHSC-based management program and its determinants.
Methods: The study enrolled 3191 patients (mean age of 70 ± 10 years, 43% males) in a hypertension management
program provided by the Yulin CHSC (Chengdu, China), which had been running for 9 years. Uncontrolled BP was
defined as the systolic BP of ≥140 mmHg and/or the diastolic BP of ≥90 mmHg, and its associated factors were
analyzed by using logistic regression.
Results: The duration of stay in the program was 33 ± 25 months. When compared with the BP at entry, the recent
BP was significantly lowered (147 ± 17 vs. 133 ± 8 mmHg; 83 ± 11 vs. 75 ± 6 mmHg) and the BP control rate was
dramatically increased (32 vs. 85%) (all p < 0.001). The age of >70 years [1.40 (odds ratio), 1.15-1.71 (95% confidence
interval)], female gender (0.76, 0.63-0.93), longer stay of >33 months (0.77, 0.63-0.94), doctor in charge (0.97, 0.95-0.99),
and the use of calcium channel blocker (1.35, 1.09-1.67) were significantly related to uncontrolled BP at the recent
follow up (all p < 0.05).
Conclusions: This CHSC-run hypertension program provides an ideal platform of multi-intervention management,
which is effective in achieving higher BP control rate in community patient population. However, the BP control status
could be affected by age, gender and adherence of the patients, as well as practice behavior of the doctors.
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Hypertension is a major cardiovascular disease and con-
fers the highest risk attributable to cardiovascular death
[1,2]. Low rates of awareness, treatment and control on
hypertension pose a very serious public health problem
worldwide, in particular in China and other developing
countries [3]. Blood pressure (BP) control rate is sug-
gested to be closely associated with provider response to
uncontrolled BP and patient adherence to treatment rec-
ommendation [4-6]. Therefore, the measures to improve* Correspondence: qzhang2000cn@yahoo.com; zengzhi@cd120.com
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unless otherwise stated.both aspects should be considered, such as training of
care provider, communication between care provider and
patient, patient education, self-management and family
support [6-15]. In the last decade, China has started
to integrate hypertension control into its health care
reform policy that emphasizes both prevention and ma-
nagement of chronic non-communicable diseases. Con-
sequently, community health service center (CHSC) as a
major model of primary care in China is activated to im-
plement comprehensive management program for hyper-
tensive patients living in the community [16-21]. The use
of community health facilities has been widespread for
non-communicable diseases and reported in high-income
countries but there are almost no studies from low- andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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fore, the present study aimed to evaluate the effectiveness
of a CHSC-based BP management program in China and
analyze the determinants of suboptimal BP control in this
multi-intervention modality.
Methods
Hypertension disease management program
This program was established in 2004 when the Yulin
CHSC (Chengdu, China) was selected as a sample center
of chronic non-communicable disease management in
China. In 2007, the management of hypertensive patients
was included as a basic service item of every CHSC by the
national laws [19,20]. The scope and content of the study
program were therefore modified according to the na-
tional regulations. Basically, the program provides 4 times
of scheduled face-to-face follow-up annually and one
check-up for every registered patient. However, more
frequent follow-up is encouraged among the patients, e.g.
once a month. Each follow-up contains multiple essential
interventions: (1) BP measurement; (2) assessment of
symptoms; (3) heart rate and weight measurement; (4)
record of compliance on lifestyle modification and medi-
cation; and (5) prescription and patient education. This
management program was approved by the local ethics
committee of the Yulin CHSC and its cluster.
Of note, it is a real life disease management program,
in which the patients are allowed to come in or drop out
at any time and not a pre-specified antihypertensive
regimen is adopted. Therefore, initial and maintenance
treatment plans for the study patients are made by the
doctors based on their clinical judgments and changes of
medication are allowed at any time in the program. How-
ever, in case of refractory hypertension, hypertension ur-
gencies or significant comorbidies, the patients should be
referred to local hospitals of higher levels. The principles
of face-to-face patient education at each follow-up are to
emphasize adherence to medication and lifestyle modifica-
tion, however, it is allowed to be individualized between
doctor and patient. The management program also pro-
vides open classes of patient education on hypertension,
usually once a month. Furthermore, a third part is in-
vited to conduct quality control in the program, by giving
phone calls to randomly selected patients for details of the
services they have received. The primary BP target of the
management is set to the 140/90 mmHg criteria for all
participants in the program regardless of their comorbi-
dies, which appears simple and feasible in the CHSC
setting [3,23,24]. Furthermore, the BP control rate under
this cutoff value becomes the parameter of management
efficiency evaluated by the CHSC authority.
Baseline characteristics of the patients and the BP mea-
surements during follow-up are stored in a dedicated
database for the program. The diagnosis of diabetes isestablished according to concurrent guidelines [25,26].
The habit of smoking or drinking is recorded according to
the patient’s self-report. Smoking is graded as “never”,
“light” (≤10 cigarettes/day) and “heavy” (>10 cigarettes/
day), in which the latter two are labeled as “yes”. Drinking
is graded as “never”, “infrequent” (≤twice/week, >1 glass
of wine or equivalent for each time) and “frequent”
(>twice/week), in which the latter two are labeled as “yes”.
Patients
Potential candidates of the management program are
those with essential hypertension and the age of ≥35
years, who live in the Yulin community. The hyper-
tensive patients (treated or not treated) found at family
medicine clinic at the CHSC, regular health promotion
program and home visit in the residential areas were all
invited. Unfortunately, some subjects did refuse to par-
ticipate with unaddressed reasons but the number of
patients who refused was not recorded. Those patients
who agreed to participate were recruited in the program
and each of them was asked to provide an informed con-
sent. As a result, the number of patients in the program
has been increasing over the years, from several hun-
dreds to several thousands. Until the data collection,
3389 patients were enrolled in the program and the rate
of drop-out during the 9 years was 3.3%. Although the
reasons of drop-out were not recorded for each case,
they were mainly poor compliance, move out of the com-
munity and referral to higher level hospital due to disease
complexity.
Doctors
Fourteen family medicine doctors at the Yulin CHSC
have been taking care of the recruited hypertensive
patients in the program. Among them, 12 (86%) doctors
completed a full-time 5-year medical program with a
bachelor’s degree in medical school while the other two
doctors had 3 years of medicine related training with a
medical diploma in technical college. All the doctors
also received a part-time training in family medicine for
6 or 12 months. Standardized training was provided to
the doctors on how to run the program prior to its com-
mencement and whenever needed throughout the pro-
gram. However, real practice behavior of the doctors are
based on their own clinical judgments, but not pre-
specified by the program.
Data collection and analysis
This study is an analysis of the data collected prospec-
tively in the BP management program since its com-
mencement in 2004. The data for analysis were exported
from the program database in May, 2012. The patients
with the duration of stay in the program <1 month or
the times of follow-up <2 were excluded. Those who
Table 1 Baseline characteristics of the patients enrolled
in the program
Patients n = 3191
Age, years 70 ± 10
≤65 years, % 30
66-79 years, % 54
≥80 years, % 16
Gender, male vs. female, % 43 vs. 57
BMI, kg/m2 23 ± 3
SBP at entry, mmHg 147 ± 17
Uncontrolled SBP (≥140 mmHg) at entry, % 66
DBP at entry, mmHg 83 ± 11
Uncontrolled DBP (≥90 mmHg) at entry, % 37




BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.
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of visit from January to May, 2012 were regarded as
drop-out cases and therefore excluded. The first BP
measurement was labeled as the BP at entry, while the
highest office BP measured during January to May, 2012
was labeled as the recent BP. The BP measurements
during follow-up were grouped by the calendar year
after entry (as the 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 8th,
9th year after entry). Optimal or controlled BP was
defined as the systolic BP (SBP) of <140 mmHg and the
diastolic BP (DBP) of <90 mmHg, while suboptimal or
uncontrolled BP as either the SBP of ≥140 mmHg or the
DBP of ≥90 mmHg [3,23,24]. This was indeed the BP
target predefined by the management program for all re-
cruited patients. The times of visit and optimal BP con-
trol in each year were recorded for each patient, as well
as the highest SBP and DBP (regarded as the SBP and
DBP of the year). Subsequently, the control rates of SBP
and DBP in the study population were calculated ac-
cording to the SBP and DBP of the year in each patient,
respectively. In addition, the demographic data, comor-
bidities, and BP-lowering medications at the last follow-
up were collected.
Statistics
The data were analyzed using a dedicated software (SPSS
for Windows, version 17.0.0, SPSS Inc., Chicago, Illinois,
USA). Continuous variables were expressed as mean ±
standard deviation, while categorical data were summa-
rized as frequencies and percentages. Paired student-t
test or Pearson Chi-square test was used when appro-
priate. Multivariable logistic regression was adopted to
find the associated factors of the recent BP control
status. A p value of <0.05 was considered as statistically
significant.
Results
Finally, 3191 patients were included in the data analysis
(Table 1). The majority of patients (2177 out of 3191
patients, 68%) had uncontrolled BP with the mean SBP
of 147 ± 17 mmHg and the mean DBP of 83 ± 11 mmHg
at entry.
The mean duration of stay in the program was 33 ± 25
(1 to 100) months for the study population. 1196 (38%)
patients had stayed for less than 24 months, 1544 (48%)
patients had stayed for 24–60 months, and 451 (14%)
patients had stayed for more than 60 months. The visits
from the 1st to 9th year were 6 ± 4, 7 ± 5, 7 ± 4, 6 ± 4,
6 ± 4, 6 ± 4, 4 ± 3, 5 ± 3 and 3 ± 1, respectively. Both the
SBP and DBP during follow-up were reduced (Figure 1a)
over the years after entry, and the control rates were
improved (Figure 1b). The total number of visit counted
67935 in the study population with 58904 (87%) records
of controlled BP.The number of patients who were taking antihyper-
tensive medication at the last follow-up counted 2782
(87%). 2058 (65%) patients were receiving calcium chan-
nel blocker (CCB), 841 (26%) patients were receiving
angiotensin converting enzyme inhibitor or angiotensin
receptor blocker, 447 (14%) patients were receiving β
blocker, 121 (4%) patients were receiving diuretic and
237 (7%) patients were receiving other medicines. Among
them, 823 (26%) patients were put on a combination ther-
apy of two or more drugs. The recent SBP was 133 ±
8 mmHg with a reduction of 14 ± 17 mmHg, while the re-
cent DBP was 75 ± 6 mmHg with a reduction of 8 ±
12 mmHg after entry (both p < 0.001). By using the recent
BP, uncontrolled BP was found in 485 (15%) patients, with
uncontrolled SBP in 458 (14%) patients or uncontrolled
DBP in 98 (3%) patients. Only 377 out of 2177 (17%)
patients with uncontrolled BP at entry remained in the
uncontrolled group at the recent follow-up. On the
other hand, 108 of 1014 (11%) patients who had the
controlled BP at entry were found to have the SBP read-
ing of ≥140 mmHg and/or the DBP of ≥90 mmHg during
the recent follow-up (χ2 = 23.854, p < 0.001). Furthermore,
differences in patient management by the 14 doctors were
also found, in the number of patients under care, patients
with controlled BP and patients with uncontrolled BP
(Figure 2).
When compared between diabetic (n = 1030, 32%) and
non-diabetic (n = 2161, 68%) patients in this study, the
SBP achieved in the program was not different (133.2 ±
8.1 vs. 133.2 ± 7.7 mmHg, p = 0.894), but the DBP was
lower in the former group (74.8 ± 6.4 vs. 75.6 ± 6.5 mmHg,
p = 0.002). The BP control rate did not show any differ-
ence between the 2 groups according to the 140/90 mmHg
Figure 1 Blood pressure control over the years in the program. The mean blood pressure (BP) (systolic, dark grey bar; diastolic, light grey
bar) (a) and the BP control rate (systolic, dark grey bar; diastolic, light grey bar) (b) of the study population over the years in the program. N, the
number of patients. Data labeled as mean ± standard deviation.
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Figure 2 Differences in practice of the doctors. The ratios of the patients under care (dark grey bar, left), the patients with controlled blood
pressure (BP) (light grey bar, middle) and the patients with uncontrolled BP (grey bar, right) among the 14 family medicine doctors involved
(labeled as A to N) in the program.
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85%, p = 0.639). However, if the American Diabetes Asso-
ciation recommendation of 130/80 mmHg [27] as the op-
timal BP target was applied to the patients with coexisting
diabetes, the BP control rate became much lower in
diabetic than in non-diabetic patients (40% vs. 85%,
p < 0.001).
In order to investigate the determinants of suboptimal
BP control (the 140/90 mmHg criteria) at the recent
follow-up (optimal BP as “0” and suboptimal BP as “1”),
a multivariable logistic regression model was created in-
cluding demographics, comorbidity, medication at the
last visit, doctor and patient adherence to the program.
As shown in Table 2, the patient age of >70 years indi-
cated more difficult BP control, while the female gender
and duration of stay in the program of >33 months were
related to higher BP control rate. Not surprisingly, differ-
ent effects on the BP control status were observed in the
practice of individual doctors. Furthermore, the use of
CCB was more involved in patients with uncontrolled
BP (all p < 0.05). Interestingly, the coexistence of dia-
betes was not found to be associated with BP control in
this model, nor the habit of smoking or drinking.
Discussion
This study demonstrated that case management of
hypertension by a CHSC in China helped to improve BP
control among more than 3000 hypertensive patients in
a local residential community. It was among the very
few investigations on a real life disease management pro-
gram rather than a pre-specified treatment study. During
the mean stay of nearly 3 years in the program, the SBPwas reduced from 147 ± 17 mmHg to 133 ± 8 mmHg
and the DBP from 83 ± 11 mmHg to 75 ± 6 mmHg. The
BP control rate achieved by the program was 85%, sig-
nificantly higher than the 32% at entry. Shorter duration
of stay in the program, older age and male gender were
found to be the major determinants of suboptimal BP
control.
CHSC has gradually become a major model of primary
care in urban China since 1997, when the general policy
framework of health care reform and specifications of
health facilities started to be constructed [28,29]. There
was a fast growth in the number of CHSC during the
last decade that reached 7861 in 2011 and 84% of them
were run by the government [21]. More than that, the
scope of services provided by CHSC to local residents
has also been expanding, including health education,
family planning, immunization, rehabilitation and chro-
nic disease management. Case management of hyper-
tension as a serious chronic illness is mandated by the
“Specifications of National Basic Public Health Services”
promulgated in 2007 and reinforced in 2009 [20]. This
legalistic document sets out a number of specifications
with regard to target population, type and frequency of
service as well as evaluation of service. Therefore, it
becomes a routine work of CHSC to screen, treat and
follow up hypertensive residents in a dedicated manage-
ment program regulated by the national laws. Thirdly,
investment and subsidy in CHSC from the government
have markedly increased, and more proportions of health
facilities in CHSC are recognized by governmental health
insurance or others [21,28]. Therefore, we have to un-
derstand that the observed reduction in BP may be
Table 2 Univariable and multivariable logistic regression for uncontrolled blood pressure
Univariable analysis Multivariable analysis
Variables Uncontrolled BP, % Odds ratio p value Odds ratio p value
Age group
>70 years (n = 1780) 17.1 1.40 (1.15-1.71) 0.001 1.42 (1.16-1.74) 0.001
≤70 years (n = 1411) 12.8
Gender
Female (n = 1819) 13.7 0.76 (0.63-0.93) 0.006 0.78 (0.64-0.95) 0.013
Male (n = 1372) 17.2
Body mass index
>25 kg/m2 (n = 482) 14.9 0.98 (0.77-1.25) 0.867 1.00 (0.78-1.28) 0.978
≤25 kg/m2 (n = 2709) 15.2
Duration of stay in the program
>33 months (n = 1564) 13.5 0.77 (0.63-0.94) 0.009 0.69 (0.56-0.84) <0.001
≤33 months (n = 1627) 16.8
Family medicine doctor, A to N* 0.97 (0.95-0.99) 0.036 0.96 (0.94-0.99) 0.003
Diabetes, yes 1.05 (0.86-1.29) 0.639 1.00 (0.81-1.24) 1.000
Smoking, yes 1.06 (0.79-1.41) 0.716 1.27 (0.63-2.62) 0.523
Drinking, yes 1.03 (0.78-1.36) 0.838 0.77 (0.38-1.57) 0.470
Calcium channel blocker, yes 1.35 (1.09-1.67) 0.005 1.42 (1.14-1.77) 0.002
ACEI or ARB, yes 1.12 (0.90-1.39) 0.305 1.18 (0.94-1.48) 0.150
β blocker, yes 0.76 (0.56-1.02) 0.067 0.75 (0.56-1.02) 0.066
Diuretic, yes 1.25 (0.81-1.92) 0.310 1.57 (0.95-2.55) 0.069
ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; BP, blood pressure.
*The family medicine doctors involved in the program are labeled as A to N, as in Figure 2.
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and society system in addition to the management
program per se.
The national health care policies consolidate the infra-
structures of CHSC services to hypertensive residents,
however, the success of this program could also be
explained by some other factors. Like many community
health service centers in China that transformed from
previous local small hospitals or clinics, the Yulin CHSC
has its own pharmacy, biochemistry lab, family medicine
clinic, day care bed and health promotion unit. It provides
an ideal platform for team based multi-intervention man-
agement that suggested to be the most effective model in
BP control [6,12,15,30-35]. Being a single-center study,
the representativeness of this study could be limited to the
area where the study was performed. However, there
are large areas in Asia and Africa where similar situ-
ation exists and this study could be useful to those
groups. Unlike many treatment (pharmacological or non-
pharmacological) studies with predefined inclusion cri-
teria, exclusion criteria, intervention and follow-up period,
this real life hypertension management program provides
an easy access to a long-term care for a general population
with the disease. Therefore, the participants would beactivated to adhere to the program for their own benefits.
Currently, the Yulin center serves the community with
80734 registered residents and there are 44028 residents
aged ≥35 years. In contrast to the high control rate
achieved in the program, the enrollment percentage of
applicable residents (<10%) was much lower than the
prevalence of hypertension in general Chinese population
[3]. Of note, the percentage of patients aged >65 years was
as high as 70% that not exactly comparable to the distribu-
tion in general population. This could be attributed to the
facts that most patients with serious complications and
comorbidies were treated at higher level hospitals and
CHSC was not yet accepted as the first choice by some
patients, in particular younger generations with better
medical benefits from their workplaces. However, more
systematic and effective ways to screen and register hyper-
tensive patients living in community would be urged.
The scope of services provided by CHSC to local resi-
dents includes chronic disease management and some
other aspects such as health education, family planning,
immunization and rehabilitation. Therefore, the doctors
in the study do not contribute equally to different parts
of work at the CHSC, which explains the heterogeneous
distribution of the registered hypertensive patients among
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and training background, the 14 doctors could differ in
their practice performance that may impact on the BP
control of their own patients. Therefore, it may not be
overemphasized the importance of complying with the
current international and national practice guidelines
among community health service providers. Unlike the
generally low training level of community health ser-
vice staff in China (only 28% of general physicians have
Bachelor degree), the doctors involved in the study are un-
doubtedly able to provide better services to their patients
[36]. This would definitely be helpful of obtaining patient
satisfaction with the center’s services, in particular, their
adherence to the management program. Interestingly, a
longer duration of stay in the program was associated with
a higher BP control rate. This was rarely investigated in
previous community based studies, but indeed empha-
sized the importance of receiving persistent manage-
ment among hypertensive patients [37-40]. Therefore,
they should be informed, educated, encouraged and
reminded of adhering to the program.Limitations of the study
Firstly, the recruitment of study subjects who were largely
a self-selected group may limit the representativeness of
the findings. However, compared with a treatment study
with many inclusion and exclusion criteria, this real life
management program would be more representative of a
general population that indicated by the distribution of
patients among different age groups and both genders.
Secondly, it is useful of recording the response rate to the
program and the likely reasons for not participating. The
lack of data on mortality and the reasons of drop-out may
not be excused by the relatively low drop-out rate either.
Thirdly, the lack of control subjects in this study makes it
difficult to evaluate the actual effect size of BP manage-
ment program. However, the “absolute” control rate of
85% achieved in the program is still promising by compar-
ing to low control rate in hypertensive population. Cer-
tainly, it would be better to collect more information on
the change of medication, diabetic control, renal function,
lipid profile, amount of alcohol intake and amount of
tobacco consumption, though its feasibility would be
challenged in a CHSC program.Conclusion
The CHSC-based multi-intervention management pro-
gram for community hypertensive patients, reinforced
by the national health care reform policy of China, shows
its effectiveness to achieve a higher control rate in a more
general patient population. The BP control status in the
program is associated with adherence of the patients and
practice behavior of the doctors.Abbreviations
CHSC: Community health service center; BP: Blood pressure; SBP: Systolic
blood pressure; DBP: Diastolic blood pressure; CCB: Calcium channel blocker.
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